Veterinary Medicines

BACIVET S, 4200 IU/G, POWDER FOR USE IN DRINKING WATER, RABBITS

Authorised
  • Bacitracin-Zink
Download as PDF

Product identification

Medicine name:
BACIVET S, 4200 IU/G, POWDER FOR USE IN DRINKING WATER, RABBITS
Bacivet S, 4200 IU/g, poeder voor gebruik in drinkwater voor konijnen
Active substance:
  • Bacitracin-Zink
Target species:
  • Rabbit
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Bacitracin-Zink
    4200.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Rabbit
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA93
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation issued:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Authorisation country:
  • Netherlands
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106128
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0187/001
Concerned member states:
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Spain

Documents

Combined File of all Documents

Published:
Dutch (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."